C12N 7/06
Inactivation or attenuation by chemical treatment
Official title: {Inactivation or attenuation} by chemical treatment
C12N7/06 (Inactivation or attenuation by chemical treatment) appears on 42 US grants and 47 published applications in this corpus.
Search patents in C12N- Granted patents
- 42
- Published applications
- 47
- Assignees
- 34
- Inventors
- 103
- Latest grant
- 4 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 2 | 2 |
| 2016 | 1 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 9 |
| 2019 | 3 | 4 |
| 2020 | 6 | 5 |
| 2021 | 3 | 5 |
| 2022 | 5 | 2 |
| 2023 | 2 | 5 |
| 2024 | 5 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Virus purification4 Feb 2025US 12,214,033 B2Valneva SE
- Viral inactivation methods for continuous manufacturing of antibodies22 Oct 2024US 12,123,028 B2Bayer HealthCare LLC
- Zika virus vaccine1 Oct 2024US 12,102,673 B2Valneva Austria GmbH
- Protein purification method and kit23 Jul 2024US 12,043,849 B2Exothera L.L.C.
- Zika virus vaccine11 Jun 2024US 12,005,111 B2Valneva Austria GmbH
- Improvements in and relating to measurement of solutions30 Jul 2026US 2026/0219218 A1University of Limerick
- Zika Virus Vaccine16 Jan 2025US 2025/0018023 A1Valneva Austria GmbH
- Zika virus vaccine4 Apr 2024US 2024/0108712 A1Valneva Austria GmbH
- Zika virus vaccine20 Jul 2023US 2023/0226165 A1Valneva Austria GmbH
- Compositions and methods for producing a viral vaccine with reduced particle size13 Jul 2023US 2023/0220356 A1Seqirus UK Limited
Most cited
By later US patents
- Photodynamic inactivation of viruses in blood cell-containing compositions94US 5,120,649 ANew York Blood Center, Inc. · 1992
- Process for the sterilization of biological compositions and the product produced thereby64US 6,087,141 ANew York Blood Center, Inc. · 2000
- Process for the sterilization of biological compositions using UVA1 irradiation51US 5,658,722 ANew York Blood Center, Inc. · 1997
- Process for the sterilization of biological compositions using UVA1 irradiation33US 5,789,150 ANew York Blood Center, Inc. · 1998
- Antiviral compositions and method of use31US 5,532,215 A1996